Physician profile
Ziad Abbud
NPI 1740373489
$360,488.24
in general payments reported to CMS, 2019-2025
58 companies · $23K in 2025
The $23K reported for 2025 was more than what 99% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $26K · 2020: $60K · 2021: $103K · 2022: $65K · 2023: $42K · 2024: $42K · 2025: $23K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $92K · Food and Beverage: $13K · Travel and Lodging: $999.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $92,370.00 |
| Food and Beverage | $13,466.32 |
| Travel and Lodging | $999.09 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $153,749.26 | 2019-2025 | Jardiance |
| Esperion Therapeutics, INC. | $82,490.95 | 2020-2025 | Nexletol, Nexlizet |
| Astrazeneca Pharmaceuticals LP | $55,443.64 | 2019-2025 | Farxiga, Wainua, Lokelma |
| Cardiovascular Systems INC. | $30,751.99 | 2019-2023 | Diamondback Coronary, Diamondback Peripheral |
| Novartis Pharmaceuticals Corporation | $10,593.07 | 2019-2025 | |
| Lilly USA, LLC | $6,972.50 | 2019-2025 | Jardiance |
| Novo Nordisk INC | $4,997.58 | 2019-2025 | Wegovy, Ozempic, Rybelsus |
| Abbott Laboratories | $3,152.59 | 2019-2025 | Diamondback Peripheral, Esprit, Absolute Pro |
| Biotronik INC. | $2,158.19 | 2021-2025 | Biomonitor, Acticor 7 Vr-T Dx, Pulsar-18 T3 |
| Amgen INC. | $1,094.31 | 2019-2025 | Repatha, Repatha |
| Medtronic, INC. | $1,043.00 | 2021-2025 | Symplicity G3, Onyx Frontier, Ffrangio |
| Abiomed | $987.50 | 2020-2025 | Impella |
| Janssen Pharmaceuticals, INC | $759.67 | 2019-2024 | Xarelto |
| Kestra Medical Technology Services, INC. | $590.86 | 2023-2025 | Assure Wcd |
| Sanofi-Aventis U.S. LLC | $545.56 | 2019-2024 |
Show all 58 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arbor Pharmaceuticals, INC. | $541.25 | 2019-2021 | |
| Boston Scientific Corporation | $422.62 | 2021-2025 | Lux-Dx Insertable Cardiac Monitor, Watchman Flx, Eluvia |
| Cardinal Health 200 LLC | $398.48 | 2019-2021 | |
| Merck Sharp & Dohme LLC | $373.23 | 2021-2025 | Verquvo, Capvaxive |
| Astellas Pharma US INC | $345.78 | 2020-2021 | |
| Alnylam Pharmaceuticals INC. | $233.69 | 2019-2025 | Amvuttra, Onpattro |
| Philips North America LLC | $206.97 | 2022-2024 | (5044) Mcot |
| Scpharmaceuticals INC. | $200.83 | 2023-2025 | |
| Irhythm Technologies, INC. | $199.83 | 2020-2024 | Zio Xt Patch, Zio Monitor |
| Kowa Pharmaceuticals America, INC. | $160.86 | 2019-2022 | |
| Medtronic Vascular, INC. | $146.52 | 2019-2020 | |
| Pfizer INC. | $142.62 | 2019-2025 | |
| Cordis US Corp. | $138.56 | 2022-2023 | Brite Tip Radianz |
| Inari Medical, INC. | $117.51 | 2025 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Bayer Healthcare Pharmaceuticals INC. | $114.62 | 2022-2025 | |
| Angiodynamics, INC. | $112.65 | 2020-2023 | Venacure 1470 Pro, Auryon Laser System 100-120 Vac |
| Lexicon Pharmaceuticals, INC. | $111.56 | 2023-2024 | Inpefa |
| Regeneron Healthcare Solutions, INC. | $103.15 | 2019-2022 | |
| Heartflow, INC. | $102.63 | 2024-2025 | |
| Saranas, INC. | $91.89 | 2022 | |
| Daiichi Sankyo INC. | $80.33 | 2020-2023 | Injectafer |
| Glaxosmithkline, LLC. | $70.85 | 2025 | Arexvy, Shingrix |
| Lundbeck LLC | $69.71 | 2019-2020 | |
| Cvrx, INC. | $60.25 | 2024 | Barostim Neo System |
| Amryt Pharma Holdings LTD | $49.74 | 2020-2023 | Juxtapid |
| Impulse Dynamics (USA) INC. | $48.93 | 2022-2024 | Optimizer |
| Azurity Pharmaceuticals, INC. | $47.05 | 2024 | Edarbi |
| Kiniksa Pharmaceuticals, LTD. | $46.96 | 2022-2023 | Arcalyst |
| Akcea Therapeutics, INC. | $43.66 | 2019-2020 | |
| Bard Peripheral Vascular, INC. | $43.32 | 2022 | |
| Biosense Webster, INC. | $38.28 | 2020 | |
| Atricure, INC. | $36.45 | 2021-2024 | |
| Kiniksa Pharmaceuticals International, Plc | $35.09 | 2024 | Arcalyst |
| Bridgebio Pharma, INC. | $34.75 | 2025 | Attruby |
| Baxter Healthcare | $30.95 | 2024 | Hillrom - Carnation Ambulatory Monitor |
| E.R. Squibb & Sons, L.L.C. | $27.95 | 2020-2022 | |
| Biocompatibles, INC. | $24.37 | 2019 | |
| Teleflex LLC | $20.26 | 2025 | Arrow |
| Bardy Diagnostics, INC. | $20.00 | 2020 | |
| Edwards Lifesciences Corporation | $19.45 | 2021 | |
| Cleerly, INC. | $17.06 | 2024 | Cleerly Ischemia, Cleerly Labs |
| Emd Serono, INC. | $15.00 | 2019 | |
| Chiesi USA, INC. | $11.91 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ziad Abbud listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.